LEUKEMIA

This study tested a combination of two oral drugs, ibrutinib and venetoclax, for adults with chronic lymphocytic leukemia (CLL) that has returned or stopped responding to prior treatment. The goal was to see if using the drugs together could drive the cancer down to undetectable …

This study tested whether the drug ofatumumab could control chronic lymphocytic leukemia or small lymphocytic lymphoma that remained after patients completed chemotherapy. Participants received up to 20 infusions over two years to target residual cancer cells. The trial was termi…

This study tested whether the drug ponatinib could control an aggressive form of chronic myeloid leukemia when used as the first treatment. It involved 51 adults with newly diagnosed advanced leukemia. The trial was terminated early, and the drug carries a serious risk of causing…

This study tested if a drug called eltrombopag could help patients whose blood cell counts remained dangerously low after a stem cell transplant for leukemia, a condition known as poor graft function. The goal was to see if the drug could boost platelet, red blood cell, and white…

This study tested whether combining two drugs, CB-103 and venetoclax, could help control a hard-to-treat type of blood cancer called T-cell acute lymphoblastic leukemia (T-ALL) in adolescents and young adults. The trial was for patients aged 12 to 60 whose cancer had returned or …

This study tested if a special app on an Android phone could help cancer survivors become more physically active and improve their heart health. Participants used the app and wore a Fitbit for 3 months. The goal was to see if the app increased activity and improved blood vessel f…

This study created a registry to understand the health, wellbeing, and needs of young adults who survived cancer diagnosed between ages 18 and 39. Participants completed online surveys every 6 to 12 months to track their mental health, social support, and financial challenges. Th…